NPL and nonpapillary renal cell carcinoma: The molecular characteristics of immune subtypes indicated that the TMB, number of mutated genes, NAL, and chromosomal instability in patients with C2 tumors were higher than those in patients with C1 tumors, suggesting that ccRCC patients with the C2 subtype may respond better to mRNA vaccines.